Intracellular genomic transplant and methods of therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11903966
APP PUB NO 20190054122A1
SERIAL NO

16180867

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MINNESOTA MINING & MFG. CO./REGENTS OF THE UNIVERSITY OF MINNESOTA; INTIMA BIOSCIENCE, INC.; THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT F HEALTH AND HUMAN SERVICES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choudhry, Modassir New York, US 30 243
Moriarity, Branden Shoreview, US 34 252
Palmer, Douglas C North Bethesda, US 17 125
Restifo, Nicholas P Chevy Chase, US 47 295
Rosenberg, Steven A Potomac, US 191 3771
Webber, Beau Coon Rapids, US 34 252

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 20, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00